Health Care/Hospital

Commentary in The Lancet on the Declaration of Istanbul Sees Organ Transplantation Worldwide Threatened by Organ Trafficking and Transplant Tourism and Commercialism

BOSTON, Mass., July 4 /Xinhua-PRNewswire/ -- The July 5 issue of the leading medical journal, The Lancet, highlights the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, an important affirmation of ethical principles and practices adopted on May 2, 2008, at an Internation...

2008-07-04 06:30 595

Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program

XI’AN, China, July 3 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in China, announced...

2008-07-03 20:30 678

Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S

BETHESDA, Md. July 2 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX), an independent American provider of international healthcare services and Western healthcare products in the People’s Republic of China, today announced that it has received long-awaited approval from the S...

2008-07-03 07:49 922

Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology

BIOCITECH, France, July 4 /Xinhua-PRNewswire/ -- Cellectis SA today announced the signature of an agreement with Regeneron Pharmaceuticals, Inc. over the use of Cellectis’ patents covering certain uses of homologous recombination for the generation of innovative human therapies, including...

2008-07-04 00:00 682

China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT

NEW YORK and HAIKOU CITY, China, July 3 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced that the management will present at the Colli...

2008-07-03 01:27 687

Nabriva Therapeutics Announces Appointment of New CEO

VIENNA, Austria, July 3 /Xinhua-PRNewswire/ -- Nabriva Therapeutics, a specialist in antibiotics development, announces that Dr. George Golumbeski has been appointed as Chief Executive Officer of the Company. Dr. Golumbeski brings to the team nearly twenty years of industry experience ser...

2008-07-03 14:00 669

WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR

SHANGHAI, China, July 2 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Mr. Bob Zhu as Vice President...

2008-07-03 05:17 880

WHO Moves to Reduce Gender Inequalities

MANILA, Philippines, July 2 /Xinhua-PRNewswire/ -- The World Health Organization (WHO) today emphasized that measures can be taken to reduce inequalities in health arising from societal norms about what is considered appropriate for men and women. (Logo: http://www.prnasia.com/sa/20061102...

2008-07-02 08:59 572

Renhuang Pharmaceuticals, Inc.'s Laboratory Recognized by Heilongjiang Science and Technology Institute

HARBIN, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today announced that its wholly-owned Traditional Chinese Medicine Extract and ...

2008-07-01 20:00 654

3SBio Inc. Announces Filing of Annual Report on Form 20-F

SHENYANG, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on ...

2008-07-01 20:30 561

China Yingxia International, Inc. Announces the Appointment of Alice Lee Rogers as a Board Director

HARBIN, China, June 30 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health food industry engaged in the development, manufacture and distribution of organic nutritional food products, s...

2008-06-30 22:30 547

Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine

BEIJING, June 30 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the initiation of volunteer enrollment in its Phase II clinical trial for its split pandemic influenza vaccine. The preliminary results from this study are expecte...

2008-06-30 20:00 774

China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results

SHANGHAI, China, June 30 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will host a conference call ...

2008-06-30 20:00 579

China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province

TAIAN CITY, Shandong, China, June 30 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company recei...

2008-06-30 20:00 618

China Medical Technologies Files Annual Report on Form 20-F with the SEC

BEIJING, June 27 /Xinhua-PRNewswire/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today...

2008-06-27 23:15 603

European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder

INDIANAPOLIS, June 27 /Xinhua-PRNewswire/ -- Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion supporting the approval of Cymbalta(R) (dulo...

2008-06-27 14:00 530

BMP Sunstone Announces Official Launch of Ferriprox in PRC

Company Holds Launch Events Throughout Cities in Guangdong and Guangxi Provinces PLYMOUTH MEETING, Pa., June 26 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP; "BMP Sunstone" or the "Company") today announced the official launch of Ferriprox in the People's Republic ...

2008-06-26 21:57 720

Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation

-- Avastin is the Only Biologic Proven to Extend Life in Patients With Normal K-Ras Gene BASEL, Switzerland, June 26 /Xinhua-PRNewswire/ -- Data presented today at the 10th World Congress on Gastrointestinal Cancer (WCGC) in Barcelona confirm that Avastin (bevacizumab) significantly...

2008-06-26 19:54 624

China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company

SHANGHAI, China, June 26 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it signed a...

2008-06-26 20:00 561

China's Leading Healthcare Market Player Records 200% Increase in Profits and Earnings

HONG KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Sock Code: 8180.HK) today is pleased to announce its annual results for the financial year ended 31 March 2008. Driven by remarkable organic growth of core businesses and exc...

2008-06-25 17:27 692
1 ... 711712713714715716717 ... 757